Margaret Johnson
Assistant Professor of Neurosurgery
I am a neuro-oncologist, neurologist, and palliative care physician at the Preston Robert Tisch Brain Tumor Center. I also provide neuro-oncology expertise for the National Tele-Oncology Program and National Precision Oncology Program at the Veteran's Health Administration. My clinical and research interests encompass supportive care and palliative care with a special interest in older adults with brain tumors. The incidence of malignant brain tumors like glioblastoma and non-malignant tumors like meningioma affect aging populations and it is crucial to be able to provide better care for these patients.
Current Appointments & Affiliations
- Assistant Professor of Neurosurgery, Neurosurgery, Neurosurgery 2021
- Assistant Professor in Neurology, Neurology, General & Community Neurology, Neurology 2021
- Member of the Duke Cancer Institute, Duke Cancer Institute, Institutes and Centers 2018
Contact Information
- 047 Baker House, Trent Drive, Box 3624, Durham, NC 27710
- 047 Baker House, Trent Drive, Box 3624, Durham, NC 27710
-
margaret.o.johnson@duke.edu
- Background
-
Education, Training, & Certifications
- M.D., Tulane University, School of Medicine 2011
- M.P.H., The George Washington University 2006
- B.A., Northwestern University 2001
-
Previous Appointments & Affiliations
- Medical Instructor of Neurology, Neurology, General & Community Neurology, Neurology 2017 - 2021
- Assistant Professor of Neurosurgery, Neurosurgery, Neurosurgery 2020
- Medical Instructor in the Department of Neurosurgery, Neurosurgery, Neurosurgery 2017 - 2020
- Expertise
-
Subject Headings
- Research
-
Selected Grants
- Phase 2/3, Randomized, Multicenter Study to Evaluate the Efficacy and Safety of REC-2282 in Participants with NF2 Mutated Meningiomas awarded by Recursion Pharmaceuticals, Inc 2022 - 2027
- A Randomized Phase II Study of Nivolumab and Temozolomide vs Temozolomide alone in newly diagnosed elderly patients with Glioblastoma (NUTMEG) awarded by University of Sydney 2020 - 2022
- Publications & Artistic Works
-
Selected Publications
-
Academic Articles
-
Broom, Alex, Leah Williams Veazey, Katherine Kenny, Imogen Harper, Michelle Peterie, Alexander Page, Nicole Cort, et al. “The Enduring Effects of COVID for Cancer Care: Learning from Real-Life Clinical Practice.” Clin Cancer Res 29, no. 9 (May 1, 2023): 1670–77. https://doi.org/10.1158/1078-0432.CCR-23-0151.Full Text Link to Item
-
McCray, Edwin, Romaric Waguia, Rafael de la Garza Ramos, Meghan J. Price, Theresa Williamson, Tara Dalton, Daniel M. Sciubba, et al. “Racial disparities in inpatient clinical presentation, treatment, and outcomes in brain metastasis.” Neurooncol Pract 10, no. 1 (February 2023): 62–70. https://doi.org/10.1093/nop/npac061.Full Text Open Access Copy Link to Item
-
Crooms, Rita C., Margaret O. Johnson, Heather Leeper, Ambereen Mehta, Michelle McWhirter, and Akanksha Sharma. “Easing the Journey-an Updated Review of Palliative Care for the Patient with High-Grade Glioma.” Curr Oncol Rep 24, no. 4 (April 2022): 501–15. https://doi.org/10.1007/s11912-022-01210-6.Full Text Link to Item
-
Kang, Jennifer H., Meghan Price, Tara Dalton, Luis Ramirez, Peter E. Fecci, Arif H. Kamal, Margaret O. Johnson, Katherine B. Peters, and Courtney R. Goodwin. “Palliative Care Use for Critically Ill Patients With Brain Metastases.” J Pain Symptom Manage 62, no. 5 (November 2021): 927–35. https://doi.org/10.1016/j.jpainsymman.2021.05.003.Full Text Link to Item
-
Kang, Jennifer H., Christa B. Swisher, Evan D. Buckley, James E. Herndon, Eric S. Lipp, John P. Kirkpatrick, Annick Desjardins, et al. “Primary brain tumor patients admitted to a US intensive care unit: a descriptive analysis.” Cns Oncol 10, no. 3 (September 1, 2021): CNS77. https://doi.org/10.2217/cns-2021-0009.Full Text Open Access Copy Link to Item
-
Kim, Miri, Erik Ladomersky, Andreas Mozny, Masha Kocherginsky, Kaitlyn O’Shea, Zachary Z. Reinstein, Lijie Zhai, et al. “Glioblastoma as an age-related neurological disorder in adults.” Neurooncol Adv 3, no. 1 (2021): vdab125. https://doi.org/10.1093/noajnl/vdab125.Full Text Open Access Copy Link to Item
-
Lee, Jessica W., John P. Kirkpatrick, Frances McSherry, James E. Herndon, Eric S. Lipp, Annick Desjardins, Dina M. Randazzo, et al. “Adjuvant Radiation in Older Patients With Glioblastoma: A Retrospective Single Institution Analysis.” Front Oncol 11 (2021): 631618. https://doi.org/10.3389/fonc.2021.631618.Full Text Open Access Copy Link to Item
-
Patel, Mallika P., John P. Kirkpatrick, Margaret O. Johnson, Patrick Healy, James E. Herndon, Eric S. Lipp, Elizabeth S. Miller, et al. “Patterns of relapse after successful completion of initial therapy in primary central nervous system lymphoma: a case series.” J Neurooncol 147, no. 2 (April 2020): 477–83. https://doi.org/10.1007/s11060-020-03446-3.Full Text Link to Item
-
Johnson, Margaret O., John P. Kirkpatrick, Mallika P. Patel, Annick Desjardins, Dina M. Randazzo, Henry S. Friedman, David M. Ashley, and Katherine B. Peters. “The role of chemotherapy in the treatment of central neurocytoma.” Cns Oncol 8, no. 3 (November 1, 2019): CNS41. https://doi.org/10.2217/cns-2019-0012.Full Text Open Access Copy Link to Item
-
Shen, Erica, Margaret O. Johnson, Jessica W. Lee, Eric S. Lipp, Dina M. Randazzo, Annick Desjardins, Roger E. McLendon, et al. “Performance of a nomogram for IDH-wild-type glioblastoma patient survival in an elderly cohort.” Neurooncol Adv 1, no. 1 (2019): vdz036. https://doi.org/10.1093/noajnl/vdz036.Full Text Link to Item
-
Johnson, Margaret O., Samuel Frank, Matthew Mendlik, and David Casarett. “Utilization of Hospice Services in a Population of Patients With Huntington's Disease.” J Pain Symptom Manage 55, no. 2 (February 2018): 440–43. https://doi.org/10.1016/j.jpainsymman.2017.09.004.Full Text Link to Item
-
Nasrallah, MacLean P., Ilya M. Nasrallah, Marisa S. Prelack, Margaret O. Johnson, Travis B. Lewis, Michael Rubenstein, Jane E. Minturn, et al. “19-Year-Old Male with Headaches and a Possible Seizure.” Brain Pathology 27, no. 4 (July 5, 2017): 557–58. https://doi.org/10.1111/bpa.12529.Full Text Link to Item
-
-
Conference Papers
-
Harrison, Rebecca A., Nazanin K. Majd, Margaret O. Johnson, Diana L. Urbauer, Vinay Puduvalli, and Mustafa Khasraw. “Characterization of industry relationships in oncology.” In Cancer, 2023. https://doi.org/10.1002/cncr.34852.Full Text
-
Bell, April, Margaret Johnson, Erik Ladomersky, Kim Miri, Junfei Zhao, Jason Miska, Lijie Zhai, et al. “TMIC-15. AGE-RELATED MARKERS FOR SENESCENCE INCREASE IN THE OLDER ADULT EXTRATUMORAL MOUSE BRAIN DUE TO GLIOBLASTOMA.” In Neuro Oncology, 7:vii274–vii274. Oxford University Press, 2022. https://doi.org/10.1093/neuonc/noac209.1059.Full Text Open Access Copy Link to Item
-
Bell, April, Margaret Johnson, Erik Ladomersky, Kim Miri, Junfei Zhao, Jason Miska, Lijie Zhai, et al. “TMIC-15. AGE-RELATED MARKERS FOR SENESCENCE INCREASE IN THE OLDER ADULT EXTRATUMORAL MOUSE BRAIN DUE TO GLIOBLASTOMA.” In Neuro Oncology, 7:vii274–vii274. Oxford University Press, 2022. https://doi.org/10.1093/neuonc/noac209.1059.Full Text Open Access Copy Link to Item
-
Affronti, Mary Lou, Mallika Patel, Erin Severance, Charles Loughlin, Claire Bradbury, James E. I. I. Herndon, Kendra Boyd, et al. “PHASE II RANDOMIZED STUDY TO EVALUATE EFFICACY AND SATISFACTION OF ROLAPITANT PLUS ONDANSETRON VS. ONDANSETRON MONOTHERAPY IN PREVENTING NAUSEA/VOMITING FOR GLIOMAS RECEIVING RADIATION/ TEMOZOLOMIDE.” In Neuro Oncology, 24:242–242, 2022.Link to Item
-
Desjardins, Annick, Vidya Chandramohan, Daniel Landi, Katherine B. Peters, Margaret Johnson, Mustafa Khasraw, Justin Low, et al. “DOSE ESCALATION TRIAL OF FC-ENGINEERED ANTI-CD40 MONOCLONAL ANTIBODY (2141-V11) ADMINISTERED INTRATUMORALLY WITH D2C7-IT VIA CONVECTION-ENHANCED DELIVERY (CED) FOR RECURRENT MALIGNANT GLIOMAS (RMGS).” In Neuro Oncology, 24:65–65, 2022.Link to Item
-
Desjardins, Annick, Vidyalakshmi Chandramohan, Daniel B. Landi, Margaret O. Johnson, Mustafa Khasraw, Katherine B. Peters, Justin Low, et al. “A phase 1 trial of D2C7-it in combination with an Fc-engineered anti-CD40 monoclonal antibody (2141-V11) administered intratumorally via convectionenhanced delivery for adult patients with recurrent malignant glioma (MG).” In Journal of Clinical Oncology, Vol. 40, 2022.Link to Item
-
Johnson, Margaret, April Bell, Yajas Shah, Kayla Viets-Layng, Elizabeth Mauer, Joanne Xiu, Olivier Elemento, et al. “THE GENOMIC, TRANSCRIPTOMIC, AND EPIGENOMIC LANDSCAPE OF ISOCITRATE DEHYDROGENASE WILD TYPE GLIOBLASTOMA ACROSS THE AGE CONTINUUM.” In Neuro Oncology, 24:13–14, 2022.Link to Item
-
Johnson, Margaret, Jennifer Durling, Casey B. Brown, Mustafa Khasraw, Zoey Petitt, Nicole Cort, Eric S. Lipp, et al. “A RETROSPECTIVE ANALYSIS OF THE IMPACT OF THE COVID-19 INFECTION ON NEURO-ONCOLOGY CARE AND PATIENT OUTCOMES: A TWO-SITE STUDY.” In Neuro Oncology, 24:206–7, 2022.Link to Item
-
Leiman, David A., Alice Parish, Seth Cohen, Donna Niedzwiecki, and Margaret O. Johnson. “Higher Rates of Dysphagia Incidence Among Patients With Malignant Primary Brain Tumors Compared to Brain Metastases: A National Study of Medicare Beneficiaries.” In American Journal of Gastroenterology, 117:S277–S277, 2022.Link to Item
-
Sim, Hao-Wen, Zarnie Lwin, Elizabeth Barnes, Kerrie McDonald, Sonia Yip, Roel Verhaak, Amy Heimberger, et al. “NUTMEG: A RANDOMIZED PHASE II STUDY OF NIVOLUMAB AND TEMOZOLOMIDE VERSUS TEMOZOLOMIDE ALONE IN NEWLY DIAGNOSED ELDERLY PATIENTS WITH GLIOBLASTOMA.” In Neuro Oncology, 24:65–65, 2022.Link to Item
-
Singh, Kirit, Matthew Foster, Elizabeth S. Miller, Simon Gregory, Kent J. Weinhold, David M. Ashley, Annick Desjardins, et al. “A phase 0/surgical window-of-opportunity study in progress, evaluating evolocumab in patients with high-grade glioma or glioblastoma.” In Journal of Clinical Oncology, Vol. 40, 2022.Link to Item
-
Batich, Kristen, Duane Mitchell, Patrick Healy, James Herndon, Gloria Broadwater, Gunn Michael, Min-Nung Huang, et al. “CTIM-10. REPRODUCIBILITY OF CLINICAL TRIALS USING CMV-TARGETED DENDRITIC CELL VACCINES IN PATIENTS WITH GLIOBLASTOMA.” In Neuro Oncology, 23:vi51–vi51. Oxford University Press (OUP), 2021. https://doi.org/10.1093/neuonc/noab196.202.Full Text Open Access Copy Link to Item
-
Johnson, Margaret, Mustafa Khasraw, Jung-Young Kim, Nicole Cort, James Herndon, Luis Ramirez, Eric Lipp, et al. “QOLP-28. COMPARING KNOWLEDGE OF AND BELIEFS ABOUT PALLIATIVE CARE AMONG NEURO-ONCOLOGY PATIENTS, CAREGIVERS, PROVIDERS AND A NATIONALLY-REPRESENTATIVE U.S. SAMPLE.” In Neuro Oncology, 23:vi189–vi189. Oxford University Press (OUP), 2021. https://doi.org/10.1093/neuonc/noab196.748.Full Text Open Access Copy Link to Item
-
Peters, Katherine, Mallika Patel, Candice Alford, Gerardo Chavez, Jung-Young Kim, Jennifer Durling, Tracy Novack, et al. “INNV-20. RADIOGRAPHIC RESPONSE AND SEIZURE CONTROL IN IDH1 MUTANT GLIOMA PATIENTS USING IVOSIDENIB.” In Neuro Oncology, 23:vi109–vi109. Oxford University Press (OUP), 2021. https://doi.org/10.1093/neuonc/noab196.431.Full Text Open Access Copy Link to Item
-
Peters, Katherine, Mary Affronti, Jung-Young Kim, Mallika Patel, Margaret Johnson, David Bartlett, Nicole Cort, et al. “QOLP-10. A LONGITUDINAL OBSERVATIONAL STUDY OF EXERCISE BEHAVIOR IN GLIOBLASTOMA PATIENTS TREATED WITH TUMOR-TREATING FIELDS.” In Neuro Oncology, 23:vi184–85. Oxford University Press (OUP), 2021. https://doi.org/10.1093/neuonc/noab196.731.Full Text Open Access Copy Link to Item
-
Petitt, Zoey, James Herndon, Oren Gottfried, Christina Cone, Daniel Landi, Mustafa Khasraw, Henry Friedman, et al. “INNV-31. NEURO-ONCOLOGY OUTPATIENT SATISFACTION IS MAINTAINED IN THE ERA OF COVID-19 TELEMEDICINE.” In Neuro Oncology, 23:vi112–vi112. Oxford University Press (OUP), 2021. https://doi.org/10.1093/neuonc/noab196.442.Full Text Open Access Copy
-
Thompson, Eric, Daniel Landi, Gerald Archer, Eric Lipp, Ashley Walter, Bridget Archambault, Bea Balajonda, et al. “EPCT-01. A NOVEL PEPTIDE VACCINE DIRECTED TO CMV PP65 FOR TREATMENT OF RECURRENT MALIGNANT GLIOMA AND MEDULLOBLASTOMA IN CHILDREN AND YOUNG ADULTS: PRELIMINARY RESULTS OF A PHASE I TRIAL.” In Neuro Oncology, 23:i46–i46. Oxford University Press (OUP), 2021. https://doi.org/10.1093/neuonc/noab090.187.Full Text Link to Item
-
Johnson, Margaret O., Joanne Xiu, Michael J. Glantz, Jia Zeng, Clark C. Chen, Erin M. Dunbar, Ekokobe Fonkem, et al. “The mutational landscape of older patients with IDH wild-type glioblastoma (GBM).” In Journal of Clinical Oncology, 39:e14033–e14033. American Society of Clinical Oncology (ASCO), 2021. https://doi.org/10.1200/jco.2021.39.15_suppl.e14033.Full Text
-
Batich, Kristen, Duane Mitchell, Patrick Healy, James Herndon, Gloria Broadwater, Gunn Michael, Min-Nung Huang, et al. “REPRODUCIBILITY OF CLINICAL TRIALS USING CMV-TARGETED DENDRITIC CELL VACCINES IN PATIENTS WITH GLIOBLASTOMA.” In Neuro Oncology, 23:51–51, 2021.Link to Item
-
Johnson, Margaret, Mustafa Khasraw, Jung-Young Kim, Nicole Cort, James Herndon, Luis Ramirez, Eric Lipp, et al. “COMPARING KNOWLEDGE OF AND BELIEFS ABOUT PALLIATIVE CARE AMONG NEURO-ONCOLOGY PATIENTS, CAREGIVERS, PROVIDERS AND A NATIONALLY-REPRESENTATIVE US SAMPLE.” In Neuro Oncology, 23:189–189, 2021.Link to Item
-
Peters, Katherine, Mallika Patel, Candice Alford, Gerardo Chavez, Jung-Young Kim, Jennifer Durling, Tracy Novack, et al. “RADIOGRAPHIC RESPONSE AND SEIZURE CONTROL IN IDH1 MUTANT GLIOMA PATIENTS USING IVOSIDENIB.” In Neuro Oncology, 23:109–109, 2021.Link to Item
-
Peters, Katherine, Mary Affronti, Jung-Young Kim, Mallika Patel, Margaret Johnson, David Bartlett, Nicole Cort, et al. “A LONGITUDINAL OBSERVATIONAL STUDY OF EXERCISE BEHAVIOR IN GLIOBLASTOMA PATIENTS TREATED WITH TUMOR-TREATING FIELDS.” In Neuro Oncology, 23:184–85, 2021.Link to Item
-
Petitt, Zoey, James Herndon, Oren Gottfried, Christina Cone, Daniel Landi, Mustafa Khasraw, Henry Friedman, et al. “NEURO-ONCOLOGY OUTPATIENT SATISFACTION IS MAINTAINED IN THE ERA OF COVID-19 TELEMEDICINE.” In Neuro Oncology, 23:112–112, 2021.Link to Item
-
Thompson, Eric, Daniel Landi, Eric Lipp, Bea Balajonda, James Herndon, Evan Buckley, Charlene Flahiff, et al. “CTIM-21. PEPTIDE VACCINE DIRECTED TO CMV pp65 FOR TREATMENT OF RECURRENT MALIGNANT GLIOMA AND MEDULLOBLASTOMA IN CHILDREN AND YOUNG ADULTS: PRELIMINARY RESULTS OF A PHASE I TRIAL.” In Neuro Oncology, 22:ii37–ii37. Oxford University Press (OUP), 2020. https://doi.org/10.1093/neuonc/noaa215.155.Full Text Open Access Copy Link to Item
-
Lee, J. W. C., M. O. Johnson, J. P. Kirkpatrick, F. McSherry, J. Herndon, E. S. Lipp, A. Desjardins, et al. “Outcomes Following Adjuvant Radiation Therapy in Elderly Patients with Glioblastoma: A Retrospective Single Institution Analysis.” In International Journal of Radiation Oncology*Biology*Physics, 105:E102–E102. Elsevier BV, 2020. https://doi.org/10.1016/j.ijrobp.2019.06.2296.Full Text Link to Item
-
Desjardins, Annick, Dina Randazzo, Vidyalakshmi Chandramohan, Peters Katherine B., Margaret O. Johnson, Steve Threat, Chevelle A. Bullock, et al. “Phase I trial of D2C7 immunotoxin (D2C7-IT) administered intratumorally via convection-enhanced delivery (CED) for recurrent malignant glioma (MG).” In Journal of Clinical Oncology, 38:20s-20s. American Society of Clinical Oncology, 2020. https://doi.org/10.1200/JCO.2020.38.15_suppl.2566.Full Text Link to Item
-
Cort, Nicole, Alex Broom, Katherine Kenny, Alexander Page, Jennifer Durling, Casey Brown, Eric Lipp, et al. “THE PARADOXICAL EFFECTS OF COVID-19 ON CANCER CARE IN THE NEURO-ONCOLOGY SETTING.” In Neuro Oncology, 22:26–26, 2020.Link to Item
-
Desjardins, Annick, Dina Randazzo, Vidya Chandramohan, Katherine Peters, Margaret Johnson, Daniel Landi, Mustafa Khasraw, et al. “A PHASE 1 TRIAL OF D2C7-IT IN COMBINATION WITH ATEZOLIZUMAB IN RECURRENT WHO GRADE IV MALIGNANT GLIOMA (MG).” In Neuro Oncology, 22:38–38, 2020.Link to Item
-
Desjardins, Annick, Dina Randazzo, Vidyalakshmi Chandramohan, Katherine B. Peters, Margaret O. Johnson, Stevie Threatt, Chevelle A. Bullock, et al. “Phase I trial of D2C7 immunotoxin (D2C7-IT) administered intratumorally via convection-enhanced delivery (CED) for recurrent malignant glioma (MG).” In Journal of Clinical Oncology, Vol. 38, 2020.Link to Item
-
Johnson, Margaret, James I. I. Herndon, Eric Lipp, Mary Affronti, Annick Desjardins, Manisha Bhattacharya, Henry Friedman, David Ashley, Katherine Peters, and Dina Randazzo. “PATTERNS OF DISTRESS IN OLDER PATIENTS WITH GLIOBLASTOMA: A FOLLOW-UP TO A SINGLE INSTITUTION CROSS-SECTIONAL STUDY OF DISTRESS IN PRIMARY BRAIN TUMOR PATIENTS.” In Neuro Oncology, 22:134–134, 2020.Link to Item
-
Lorimer, Cressida, Anthony Chalmers, Margaret Johnson, and Juliet Brock. “GLIOBLASTOMA IN THE OLDER PERSON - HOW DO WE DECIDE ON TREATMENT?” In Neuro Oncology, 22:118–118, 2020.Link to Item
-
Patel, Mallika, Katherine Peters, Eric Lipp, Justin Low, James I. I. Herndon, Gloria Broadwater, Margaret Johnson, Dina Randazzo, Jung-Young Kim, and Mary Affronti. “OLANZAPINE FOR REFRACTORY CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN MALIGNANT GLIOMA PATIENTS.” In Neuro Oncology, 22:175–175, 2020.Link to Item
-
Peters, Katherine B., John Kirkpatrick, I. Batinic-Haberle, Mary L. Affronti, Sarah Woodring, Deborah Iden, Eric S. Lipp, et al. “Cognitive Outcomes of Phase I Trial of Novel Metalloporphyrin Radioprotectant and Radiosensitizer in Newly Diagnosed High Grade Glioma Patients.” In Supportive Care in Cancer. Springer (part of Springer Nature), 2020.
-
Peters, Katherine, Dina Randazzo, Margaret Johnson, Jung-Young Kim, Mallika Patel, and Mary Affronti. “ENGAGING PATIENTS AND CAREGIVERS TO IMPROVE THE IMPORTANCE AND QUALITY OF SUPPORTIVE CARE RESEARCH IN NEURO-ONCOLOGY.” In Neuro Oncology, 22:180–180, 2020.Link to Item
-
Peters, Katherine, Eric Lipp, Gloria Broadwater, James I. I. Herndon, Margaret Johnson, Dina Randazzo, Annick Desjardins, Henry Friedman, David Ashley, and Mary Affronti. “CLINICAL CHARACTERISTICS OF LOW GRADE GLIOMA PATIENTS WITH NON-CANONICAL IDH1 AND IDH2 MUTATIONS.” In Neuro Oncology, 22:137–137, 2020.Link to Item
-
Randazzo, Dina, Evan Buckley, James I. I. Herndon, Nicole Cort, Mary Affronti, Eric Lipp, Annick Desjardins, et al. “A FEASIBILITY STUDY UTILIZING MINDFULNESS MEDITATION DURING CONCOMITANT CHEMORADIATION IN MALIGNANT GLIOMA PATIENTS: HEALTH-REPORTED QUALITY OF LIFE (HRQOL) RESULTS.” In Neuro Oncology, 22:179–179, 2020.Link to Item
-
Thompson, Eric, Daniel Landi, Eric Lipp, Bea Balajonda, James I. I. Herndon, Evan Buckley, Charlene Flahiff, et al. “PEPTIDE VACCINE DIRECTED TO CMV PP65 FOR TREATMENT OF RECURRENT MALIGNANT GLIOMA AND MEDULLOBLASTOMA IN CHILDREN AND YOUNG ADULTS: PRELIMINARY RESULTS OF A PHASE I TRIAL.” In Neuro Oncology, 22:37–37, 2020.Link to Item
-
Barbour, Andrew, Patrick Healy, Eric Lipp, James Herndon, Leslie Thomas, Margaret Johnson, David Ashley, et al. “CHARACTERISTICS OF SHORT-TERM SURVIVAL IN PATIENTS WITH GLIOBLASTOMA: A RETROSPECTIVE ANALYSIS.” In Neuro Oncology, 21:vi116–vi116. OXFORD UNIV PRESS INC, 2019. https://doi.org/10.1093/neuonc/noz175.486.Full Text Link to Item
-
Barbour, Andrew, Patrick Healy, Eric Lipp, James Herndon, Leslie Thomas, Margaret Johnson, David Ashley, et al. “HOUT-21. CHARACTERISTICS OF SHORT-TERM SURVIVAL IN PATIENTS WITH GLIOBLASTOMA: A RETROSPECTIVE ANALYSIS.” In Neuro Oncology, 21:vi116–vi116. Oxford University Press (OUP), 2019. https://doi.org/10.1093/neuonc/noz175.486.Full Text Open Access Copy Link to Item
-
Desjardins, Annick, Dina Randazzo, Vidya Chandramohan, Katherine Peters, Margaret Johnson, Stevie Threatt, Chevelle Bullock, et al. “DOSE FINDING AND DOSE EXPANSION TRIAL OF D2C7 IMMUNOTOXIN (D2C7-IT) ADMINISTERED INTRATUMORALLY VIA CONVECTION-ENHANCED DELIVERY (CED) FOR RECURRENT MALIGNANT GLIOMA (MG).” In Neuro Oncology, 21:vi6–vi6. OXFORD UNIV PRESS INC, 2019. https://doi.org/10.1093/neuonc/noz175.023.Full Text Link to Item
-
Desjardins, Annick, Dina Randazzo, Vidya Chandramohan, Katherine Peters, Margaret Johnson, Stevie Threatt, Chevelle Bullock, et al. “ATIM-24. DOSE FINDING AND DOSE EXPANSION TRIAL OF D2C7 IMMUNOTOXIN (D2C7-IT) ADMINISTERED INTRATUMORALLY VIA CONVECTION-ENHANCED DELIVERY (CED) FOR RECURRENT MALIGNANT GLIOMA (MG).” In Neuro Oncology, 21:vi6–vi6. Oxford University Press (OUP), 2019. https://doi.org/10.1093/neuonc/noz175.023.Full Text Link to Item
-
Peters, Katherine, Kendra Congdon, Gary Archer, Sarah Woodring, Denise Jaggers, Eric Lipp, Patrick Healy, et al. “SAFETY OF TUMOR-SPECIFIC PEPTIDE VACCINE TARGETING ISOCITRATE DEHYDROGENASE 1 MUTATION IN RECURRENT RESECTABLE LOW GRADE GLIOMA PATIENTS.” In Neuro Oncology, 21:vi8–vi8. OXFORD UNIV PRESS INC, 2019. https://doi.org/10.1093/neuonc/noz175.030.Full Text Link to Item
-
Randazzo, Dina, Jenny Jackman, James Herndon, Mary Affronti, Eric Lipp, Nicole Cort, Annick Desjardins, et al. “MINDFULNESS MEDITATION PRACTICE IN MALIGNANT GLIOMA PATIENTS THROUGHOUT CONCOMITANT RADIATION AND TEMOZOLOMIDE: A FEASIBILITY STUDY.” In Neuro Oncology, 21:vi204–vi204. OXFORD UNIV PRESS INC, 2019. https://doi.org/10.1093/neuonc/noz175.849.Full Text Link to Item
-
Johnson, Margaret, Luis Ramirez, James Herndon, Woody Massey, Eric Lipp, Mary Affronti, Jung-Young Kim, et al. “A TIME-BASED MODEL OF EARLY PALLIATIVE CARE INTERVENTION IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA, A SINGLE INSTITUTION FEASIBILITY STUDY.” In Neuro Oncology, 21:vi201–vi201. OXFORD UNIV PRESS INC, 2019. https://doi.org/10.1093/neuonc/noz175.838.Full Text Link to Item
-
Peters, K. B., J. P. Kirkpatrick, I. Batinic-Haberle, M. L. Affronti, S. Woodring, D. Iden, E. S. Lipp, et al. “First in Human Clinical Trial of a Metalloporphyrin Dual Radioprotectant and Radiosensitizer, BMX-001, in Newly Diagnosed High-Grade Glioma Undergoing Concurrent Chemoradiation.” In International Journal of Radiation Oncology*Biology*Physics, 105:E106–E106. Elsevier BV, 2019. https://doi.org/10.1016/j.ijrobp.2019.06.2305.Full Text Link to Item
-
Desjardins, Annick, Matthias Gromeier, James Emmett Herndon, Dina Randazzo, Stevie Threatt, Eric S. Lipp, Elizabeth S. Miller, et al. “Oncolytic polio/rhinovirus recombinant (PVSRIPO) against WHO grade IV malignant glioma (MG): Experience with retreatment of survivors from the phase I trial.” In Journal of Clinical Oncology, 37:101s-101s. American Society of Clinical Oncology (ASCO), 2019. https://doi.org/10.1200/JCO.2019.37.15_suppl.2060.Full Text Link to Item
-
Kang, Jennifer, Christa Swisher, John Kirkpatrick, James Herndon, Eric Lipp, Leslie Thomas, Margaret Johnson, et al. “Primary brain tumors admitted to the neurological intensive care unit: a single institution observational study.” In Neurology, 92:P1–P1. LIPPINCOTT WILLIAMS & WILKINS, 2019.Link to Item
-
Desjardins, Annick, Dina Randazzo, Vidya Chandramohan, Katherine Peters, Margaret Johnson, Leslie Thomas, Stevie Threatt, et al. “DOSE ESCALATION TRIAL OF D2C7 IMMUNOTOXIN (D2C7-IT) ADMINISTERED INTRATUMORALLY VIA CONVECTION-ENHANCED DELIVERY (CED) FOR RECURRENT MALIGNANT GLIOMA (MG).” In Neuro Oncology, 20:vi9–vi9. OXFORD UNIV PRESS INC, 2018. https://doi.org/10.1093/neuonc/noy148.031.Full Text Link to Item
-
Johnson, Margaret, John Kirkpatrick, Mallika Weant, Zachary Vaslow, Eric Lipp, James Herndon, Frances McSherry, et al. “TREATMENT PATTERNS, OUTCOMES, AND PROGNOSTIC INDICATORS IN ELDERLY PATIENTS WITH GLIOBLASTOMA: A RETROSPECTIVE SINGLE INSTITUTION ANALYSIS.” In Neuro Oncology, 20:vi117–vi117. OXFORD UNIV PRESS INC, 2018. https://doi.org/10.1093/neuonc/noy148.487.Full Text Link to Item
-
Peters, Katherine, John Kirkpatrick, Ines Batinic-Haberle, Mary Affronti, Sarah Woodring, Deborah Iden, Sujata Panta, et al. “PHASE 1 DOSE ESCALATION TRIAL OF THE SAFETY OF BMX-001 CONCURRENT WITH RADIATION THERAPY AND TEMOZOLOMIDE IN NEWLY DIAGNOSED PATIENTS WITH HIGH-GRADE GLIOMAS.” In Neuro Oncology, 20:1vi7-vi17. OXFORD UNIV PRESS INC, 2018. https://doi.org/10.1093/neuonc/noy148.061.Full Text Link to Item
-
Randazzo, Dina, John Kirkpatrick, Frances McSherry, James Herndon, Mary Affronti, Margaret Johnson, Zachary Vaslow, et al. “PSYCHOSOCIAL DISTRESS IN PATIENTS WITH RECURRENT MENINGIOMAS.” In Neuro Oncology, 20:vi217–vi217. OXFORD UNIV PRESS INC, 2018. https://doi.org/10.1093/neuonc/noy148.899.Full Text Link to Item
-
Vaslow, Zachary, John Kirkpatrick, Mary Affronti, Patrick Healy, James Herndon, Eric Lipp, Leslie Thomas, et al. “CLINICAL AND HISTOPATHOLOGICAL CHARACTERISTICS OF YOUNG ADULTS WITH GLIOBLASTOMA AT DIAGNOSIS.” In Neuro Oncology, 20:vi239–vi239. OXFORD UNIV PRESS INC, 2018. https://doi.org/10.1093/neuonc/noy148.990.Full Text Link to Item
-
Inamullah, Ovais, John Kirkpatrick, Patrick Healy, Eric Lipp, Margaret Johnson, David Ashley, Dina Randazzo, Henry Friedman, and Katherine Peters. “Adult Pilocytic Astrocytoma: Clinical Management and Prognostic Factors.” In Neurology, 90:P6–P6. LIPPINCOTT WILLIAMS & WILKINS, 2018.Link to Item
-
Vaslow, Zachary, Katherine Peters, John Kirkpatrick, Frances McSherry, James Herndon, Eric Lipp, Margaret O. Johnson, et al. “Long-term outcomes of adult patients with ependymoma.” In Neurology, 90:P6–P6. American Academy of Neurology, 2018.Link to Item
-
Johnson, Margaret O., John P. Kirkpatrick, Mallika P. Weant, Anastasie Dunn-Pirio, Annick Desjardins, Dina Randazzo, Henry S. Friedman, and Katherine B. Peters. “RARE-25. A RETROSPECTIVE, SINGLE INSTITUTION STUDY OF CENTRAL NEUROCYTOMA (2004-2016): SURVIVAL, TREATMENT, AND SUPPORTIVE CARE.” In Neuro Oncology, 19:vi215–16. Oxford University Press (OUP), 2017. https://doi.org/10.1093/neuonc/nox168.871.Full Text Link to Item
-
Desjardins, Annick, Dina Randazzo, Katherine B. Peters, Margaret O. Johnson, Woody Massey, James E. Herndon, Frances McSherry, et al. “PHASE 2 STUDY OF SYM004 FOR ADULT PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM).” In Neuro Oncology, 19:vi14–vi14. OXFORD UNIV PRESS INC, 2017. https://doi.org/10.1093/neuonc/nox168.871.Full Text Link to Item
-
Weant, Mallika P., John Kirkpatrick, Margaret O. Johnson, Ashley Dunn-Pirio, Patrick Healy, James E. Herndon, Eric Lipp, et al. “PATTERNS OF RELAPSE AFTER SUCCESSFUL COMPLETION OF INITIAL THERAPY IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA.” In Neuro Oncology, 19:vi217–vi217. Oxford University Press (OUP), 2017. https://doi.org/10.1093/neuonc/nox168.878.Full Text Link to Item
-
Johnson, Margaret, and Sarah Schmitt. “SCREENING BIOMARKERS IN GLIAL TUMORS TO IDENTIFY PREDICTORS OF SEIZURE ACTIVITY: A PROOF OF CONCEPT USING ISOCITRATE DEHYDROGENASE 1 (IDH-1) MUTATION STATUS.” In Neuro Oncology, 18:vi106–vi106. Oxford University Press (OUP), 2016. https://doi.org/10.1093/neuonc/now212.442.Full Text Link to Item
-
Desjardins, Annick, Dina Randazzo, V. Chandramohan, Katherine B. Peters, Margaret O. Johnson, Steve Threatt, James E. Herndon, et al. “Dose escalation study of D2C7-IT administered intratumorally via convection-enhanced delivery for recurrent malignant glioma.,” n.d.
-
Johnson, Margaret, and Sarah Schmitt. “Is IDH-1 status associated with seizure activity in glial tumors?,” 3:261–261, n.d.Link to Item
-
-
- Scholarly, Clinical, & Service Activities
-
Clinical Activities
-
2016- present: Neuro-oncologist within the Preston Robert Tisch Brain tumor center
2021- present: Nation Tele-oncology (NTO), Neuro-oncologist, VA
-
2016- present: Neuro-oncologist within the Preston Robert Tisch Brain tumor center
Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.